21-206
Showing 26 - 50 of 6,747
Melanoma Stage III, Melanoma Stage IV Trial in Boston, Rochester, Houston (SX-682, Pembrolizumab)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- SX-682
- Pembrolizumab
-
Boston, Massachusetts
- +4 more
Jan 26, 2022
NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Non-small Cell Lung Cancer
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Jun 27, 2023
Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- combinations of up to 3 FDA approved drugs from a panel of compounds
- (no location specified)
Jan 19, 2023
Advanced Solid Tumor Trial in Australia, China, Hong Kong (HBM4003)
Active, not recruiting
- Advanced Solid Tumor
-
Kogarah, New South Wales, Australia
- +16 more
Aug 2, 2022
Pain Management Trial in Baghdad (Non-pharmacological pain management strategies)
Completed
- Pain Management
- Non-pharmacological pain management strategies
-
Baghdad, IraqCollege of Nursing- The University of Baghdad
Jul 12, 2023
Paternal Age and Fetal Aneuploidy
Active, not recruiting
- Trisomy 21
- Optimo prenatal screening test
-
Montréal, Quebec, CanadaClinique Ovo
Aug 7, 2023
Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate
Recruiting
- Aggressive Non-Hodgkin Lymphoma
- +8 more
- Polatuzumab Vedotin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
Vision Screening Study for College Students at Nankai University
Completed
- Myoma
- No intervention
-
Tianjin, Tianjin, ChinaTiajin Eye Hospital
Jun 28, 2023
Stress, Anxiety Trial in Boston (PRISM Program Video Coach, PRISM Program Text Coach, mPRISM Program App)
Not yet recruiting
- Stress
- Anxiety
- PRISM Program Video Coach
- +2 more
-
Boston, Massachusetts
- +1 more
Sep 8, 2023
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Not yet recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Study of Subjects Who Received ICM-203 or Matching Placebo
Not yet recruiting
- Osteoarthritis, Knee
- ICM-203
- Placebo
-
Adelaide, South Australia, Australia
- +1 more
Feb 21, 2023
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in Spain, United Kingdom, United States (Azacitidine,
Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle
Recruiting
- Advanced Soft Tissue Sarcoma
- +2 more
- Nanoparticle Albumin-Bound Rapamycin
- Pazopanib hydrochloride
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Adolescent Behavior Trial in Seattle (Media Discussion and Planning Tool (MDPT))
Not yet recruiting
- Adolescent Behavior
- Media Discussion and Planning Tool (MDPT)
-
Seattle, WashingtonSeattle Children's Hospital
Feb 1, 2023
Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Seattle (drug, other,
Recruiting
- Recurrent Hodgkin Lymphoma
- +3 more
- Brentuximab Vedotin
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 4, 2022
Aerobic Endurance, Metabolism Trial in Natick (High-amylose maize starch+acetate/butyrate, Low-amylose maize starch)
Recruiting
- Aerobic Endurance
- Metabolism
- High-amylose maize starch+acetate/butyrate
- Low-amylose maize starch
-
Natick, MassachusettsUnited States Army Research Institute of Environmental Medicine
Sep 19, 2023
Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial
Completed
- Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
-
Houston, TexasM.D. Anderson Cancer Center
Aug 22, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)
Completed
- NAFLD
- Soy isoflavone
- Placebo
-
Ahvaz, Khuzestan, Iran, Islamic Republic ofAsal Neshatbini Tehrani
Oct 24, 2023
Motility Function Trial in San Francisco (High resolution solid state manometry)
Not yet recruiting
- Motility Function
- High resolution solid state manometry
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 6, 2022
Drug-drug Interactions Between Hormonal Contraceptives and
Recruiting
- HIV Infections
- +2 more
- Etonogestrel (ETG) implant
- +3 more
-
Johannesburg, South AfricaWits Reproductive Health and HIV Institute, Research Centre Clin
Feb 28, 2022
Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)
Recruiting
- Malignant Pleural Mesothelioma
- Safety
- Expansion Cohort
-
New York, New YorkIcahn School of Medicine Mount Sinai
Mar 31, 2022
Metastatic Solid Tumors Trial in Scottsdale, Santa Monica (aldoxorubicin, gemcitabine)
Completed
- Metastatic Solid Tumors
-
Scottsdale, Arizona
- +1 more
Jan 27, 2022